3

PRIMARY DOCUMENT

Company: REVIVA PHARMACEUTICALS HOLDINGS, INC.
Filed: May 15, 2020
Period of Report: May 7, 2020
Accession Number: 0000812291-20-000005

View Document ↗ View on SEC.gov ↗